Upgrade to SI Premium - Free Trial

Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 6c, Revenues Beat

November 6, 2019 4:43 PM
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q3 EPS of $0.13, $0.06 better than the analyst estimate of $0.07. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Earnings Guidance Management Comments

Next Articles